The current share price of Apollo Hospitals Enterprise is ₹7,133.00, with a market capitalization of ₹1,03,344.50. The stock is currently trading at the P/E ratio of 71.47x and it has a Debt/Equity ratio of 0.96x.
In Mar 2025, the company announced sales of ₹5,592.00 and net profit of ₹414.00. TTM ROE stands at 17.61% with promoter holding of 29.34%.
Apollo Hospitals Enterprise Limited is an India-based integrated healthcare company. The Company is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. It is engaged in hospitals and hospitals-based services. Retail Health and Diagnostics segment includes clinics and diagnostics. Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,000 beds across 71 hospitals, 6000 pharmacies and 200 clinics and diagnostic centers, as well as 150 telemedicine centers.